phamax sources anonymous patient information provided either through secondary sources (Anonymized Patient Level Data, or APLD) or primary research from selected, representative healthcare facilities, prioritizes parameters and establishes interdependencies, and analyzes unstructured data to highlight scientific nuances. Our team transforms complex transactional APLD into insights for drug utilization and prescription, cost-of-care trends, and health outcomes.
We use primary research to quantify the burden of a disease/condition and compare the impact of various interventions. We produce quantifiable patient outcomes to demonstrate product value and bring evidence-based recommendations as a powerful tool to shape healthcare policies. Finally, we determine market niches and product usage dynamics and identify untapped marketing opportunities.
Let us help you demonstrate the real-world value of your product. Contact us now, and we will develop a free concept note for you, outlining the design, timelines and cost of a potential RWE project.
Simply enter your details in the form and one of our experts will be in touch with you to discuss further.